Ivivi Technologies To Present At Brean Murray Carret & Co. Small-Cap Healthcare & Biotechnology One-on-One Conference
10 Mai 2007 - 3:54PM
Business Wire
Ivivi Technologies, Inc. (AMEX:II), a leader in non-invasive,
electrotherapeutic technology, today announced that Andre� DiMino,
Vice Chairman and Co-Chief Executive Officer, and other members of
senior management are scheduled to represent the Company at the
Brean Murray Carret & Co. Small-Cap Healthcare &
Biotechnology One-on-One Conference on Tuesday, May 15, 2007 at The
Grand Hyatt Hotel, New York, New York. The conference is comprised
of a full day of one-on-one and round table meetings. Ivivi�s round
table meeting is scheduled for 11:45 a.m. A copy of the
presentation will be available on the Investor Relations page of
the Company�s website www.ivivitechnologies.com under Events and
Presentations. About Ivivi Technologies, Inc. Based in Northvale,
NJ, Ivivi Technologies, Inc. is a medical technology company
focusing on designing, developing and commercializing its
proprietary electrotherapeutic technology platform. Ivivi�s
research and development activities are focused specifically on
pulsed electromagnetic field, or PEMF, technology, which, by
creating a therapeutic electrical current in injured soft tissue,
stimulates biochemical and physiological healing processes to help
repair the injured tissue and reduce related pain and inflammation.
The Company�s Electroceuticals� have been used in non-invasive
treatments for a wide array of conditions, including chronic
wounds, pain and edema following plastic and reconstructive surgery
and chronic inflammatory disorders. Forward-Looking Statements This
release contains "forward-looking statements" made pursuant to the
safe harbor provisions of the Private Securities Litigation Reform
Act of 1995. Forward-looking statements reflect management's
current knowledge, assumptions, judgment and expectations regarding
future performance or events. Although management believes that the
expectations reflected in such statements are reasonable, they give
no assurance that such expectations will prove to be correct and
you should be aware that actual results could differ materially
from those contained in the forward-looking statements.
Forward-looking statements are subject to a number of risks and
uncertainties, including, but not limited to, the Company�s limited
operating history, history of significant and continued operating
losses and substantial accumulated earnings deficit, difficulties
with its financial accounting controls, the failure of the market
for the Company�s products to continue to develop, the inability
for customers to receive third party reimbursement, the inability
to obtain additional capital, the inability to protect the
Company�s intellectual property, the loss of any executive officers
or key personnel or consultants, competition, changes in the
regulatory landscape or the imposition of regulations that affect
the Company�s products and other risks detailed from time to time
in the Company�s filings with the Securities and Exchange
Commission, including the Company�s registration statement on Form
SB-2. The Company assumes no obligation to update the information
contained in this press release.
Equifin (AMEX:II)
Graphique Historique de l'Action
De Août 2024 à Sept 2024
Equifin (AMEX:II)
Graphique Historique de l'Action
De Sept 2023 à Sept 2024
Real-Time news about Ivivi Technologies, Inc. (American Stock Exchange): 0 recent articles
Plus d'articles sur Ivivi Technologies, Inc.